Precure, an Allinge, Denmark-based company working on the development of a wearable device for the health industry, secured a capital investment of $500K (approx €456K). The round was led by Sparekassen Bornholm Fond’s subsidiary Sparbo Finans, Bornholm’s Business Foundation, and a private investor.
The Danish company intends to use this funding to initiate collaboration with business partners, help more companies avoid strain related musculoskeletal disorders. Part of the investment will be used for expansion purposes in Germany and the United States.
Precure develops smart wearable IoT devices, which analyse muscular activity and provide biofeedback using machine learning. The user will change behaviour, hence experience less pain, recover faster, and avoid further injuries.
This has a positive impact on people’s quality of life, adds cost and time efficiencies to companies, and it enables more effective and efficient treatment.
The smart wearable company was founded in 2016 by Carsten Scheibye, Finn Bech Andersen, Jønne Marcher, and Søren Würtz. With this platform, Precure aims to help people and companies avoid the pain and consequences of Musculoskeletal Disorder (MSD).
Main image credits:Precure
Stay tuned to Silicon Canals for more European technology news
Free field brief
The Empire File
How money, ownership, and power actually move behind the companies you think you know. Built for people who watch our documentaries. Sundays you also get The Undercurrent.
Written by
Silicon Canals Editorial Team
The Silicon Canals Editorial Team produces content across our three editorial pillars: technology and business, power and investigations, and human systems. We chronicle the systems that shape our lives, from the global infrastructure of technology to the internal infrastructure of the human mind. Articles reflect our team's collective editorial process, sourcing, drafting, fact-checking, editing, and review, rather than a single journalist's writing. Silicon Canals takes editorial responsibility for content under this byline. For more on how we work, see our editorial policy.